**
In a progressive move that could reshape mental health care for military personnel, the United States Department of Defense (DoD) is preparing to implement MDMA-assisted therapy for active-duty soldiers grappling with post-traumatic stress disorder (PTSD). Scheduled to commence next year, the initiative aims to address the psychological toll of combat while potentially enhancing service members’ resilience on the battlefield.
A New Approach to Combatting PTSD
The DoD has earmarked funding for two pivotal studies involving 186 active-duty personnel diagnosed with PTSD. Under the supervision of trained therapists from the DoD and Veterans Affairs (VA), these soldiers are set to undergo multiple sessions of therapy utilising MDMA, a substance known for its empathogenic effects. Sean O’Keefe, the deputy under secretary for personnel and readiness, is closely monitoring the developments, as outlined in a letter from January.
Rick Doblin, the founder of the Multidisciplinary Association for Psychedelic Studies (MAPS), expressed optimism about the potential benefits of this therapeutic approach, stating, “Helping people process trauma, whoever they are, is probably better than not.” His advocacy underscores a growing recognition of the importance of emotional healing in the military context.
Bipartisan Support and Legislative Backing
The funding for this innovative research was approved under the National Defence Authorization Act, signed by former President Joe Biden in December 2023. The provisions, advocated by Republican congressman Morgan Luttrell, emphasise the necessity for comprehensive healing strategies for those who serve. “Our men and women in uniform deserve every tool available to heal and stay in the fight,” Luttrell affirmed, drawing from his own experiences as a Navy Seal who has engaged in psychedelic therapy.
The urgency of this initiative was echoed by Donald Trump during an executive order signing event in April, where he highlighted the alarming suicide rates among veterans. “Since 9/11, we’ve lost over 21 times more veteran lives to suicide than on the battlefield,” Trump lamented, framing the issue as a national tragedy that demands immediate action.
Historical Context and Evolving Perspectives
Historically, the approach to treating PTSD within the military has evolved significantly. During the Second World War, barbiturates were employed to induce prolonged states of unconsciousness, temporarily alleviating symptoms for some soldiers. However, the inefficacy of such methods in providing lasting relief led to a search for more effective solutions. Recent studies suggest that psychedelics like MDMA and psilocybin may offer a more promising path towards meaningful recovery.
Yet, the potential application of these therapies raises ethical concerns. Experts like Dennis McKenna have cautioned against the risk of using psychedelics merely to enhance combat readiness. “It would be completely cynical and cruel of the government to throw them back into combat,” McKenna warned, highlighting the moral implications of utilising therapeutic advancements for military efficiency.
The Challenges Ahead
As the DoD prepares for the implementation of these studies, challenges remain regarding the psychological impact of returning soldiers to active duty after treatment. Doblin noted that some individuals might experience a relapse into PTSD symptoms when re-exposed to high-stress environments.
Internationally, similar initiatives are unfolding. In Ukraine, MAPS has trained therapists to facilitate MDMA-assisted sessions for soldiers amidst a backdrop of ongoing conflict and untreated PTSD cases. Despite the legality hurdles, some Ukrainian troops have already benefited from ketamine therapy, allowing them to return to the front lines.
Why it Matters
The implementation of MDMA-assisted therapy for US military personnel represents a significant shift in how the armed forces address mental health challenges. As the military grapples with unprecedented rates of PTSD and suicide among veterans, this initiative could pave the way for a more compassionate and effective approach to healing. The success of these studies may not only impact the lives of countless service members but could also serve as a model for addressing trauma in military contexts globally, ultimately redefining the narrative around mental health in warfare.